_1777352142843_145525226.png&w=48&q=75){kind=small}
Drug Authority's Withdrawn Medications List
The Egyptian Drug Authority announced the withdrawal and suspension of the circulation of several medications from the Egyptian market due to the appearance of counterfeit or substandard drugs, in order to protect public health. Among the withdrawn medications are those containing active ingredients such as rabeprazole, duloxetine, used to treat reflux, stomach ulcers, depression, and anxiety. The authority emphasized the importance of purchasing drugs from licensed pharmacies and avoiding unofficial sources, especially social media platforms, to prevent health risks that may range from complications in the gastrointestinal system, kidneys, and liver. It also warned against buying drugs of unknown origin, as they could cause serious health damages, and stressed the importance of verifying the medication’s packaging and batch number to distinguish between genuine and counterfeit products.
Notice: This Is an AI-Generated Summary
Comments (0)